Scientists have hypothesized that dying brain cells break apart and release proteins, including tau, which then form the tangles that are a hallmark of the disease. New research from Washington University in St. Louis shows, however, that tau secretion is actually an active process, not a byproduct of cell death—findings that could refine tau-targeting treatments for Alzheimer’s. “Our results showing that tau production is increased suggest that we might want to target tau production therapeutically.”
Read the Full Story at www.fiercebiotech.com
A new understanding of tau could refine Alzheimer’s approaches
More from ResearchMore posts in Research »
- A possible blood test for early-stage Alzheimer’s disease | Medical Xpress
- Blood Biomarkers Plus Gene Status Predict Cognitive Decline : Neurology Today
- Early Detection of Alzheimer’s Prior to Onset of Symptoms Now Possible | Science Times
- We Need New Ideas for Fighting Alzheimer’s | Scientific American
- Immune view offers clues to early Alzheimer’s